Skip to main content
. 2023 Apr 20;11:1147676. doi: 10.3389/fcell.2023.1147676

FIGURE 5.

FIGURE 5

KRAS mutation in PDAC glutamine metabolic reprogramming. KRAS mutation-containing pancreatic cancer cells have great demand for glutamine; this is also termed as “glutamine addition”. Red arrow: The expression of related gene is upregulated. Blue arrow: The expression of related gene is downregulated.